I agree that this site is using cookies. You can find further informations here.
X
Berger, Christopher A.
2098  results:
Search for persons X
?
1

The types and numbers of kinesins and dyneins transporting ..:

Beaudet, Daniel ; Berger, Christopher L. ; Hendricks, Adam G.
Journal of Biological Chemistry.  300 (2024)  6 - p. 107323 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Comparison of 3 optimized delivery strategies for completio..:

Semitala, Fred C. ; Kadota, Jillian L. ; Musinguzi, Allan...
PLOS Medicine.  21 (2024)  2 - p. e1004356 , 2024
Link: https://doi.org/10.1371/..
 
?
3

Tau acts as a selective barrier along microtubules to regul..:

Beaudet, Daniel ; Berger, Christopher L. ; Hendricks, Adam G.
Biophysical Journal.  122 (2023)  3 - p. 409a-410a , 2023
Link: https://doi.org/10.1016/..
 
?
4

Tau, microtubule dynamics, and axonal transport: New paradi..:

Cario, Alisa ; Berger, Christopher L.
BioEssays.  45 (2023)  8 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
5

Implementation, feasibility, and acceptability of 99DOTS-ba..:

Kiwanuka, Noah ; Kityamuwesi, Alex ; Crowder, Rebecca...
PLOS Digital Health.  2 (2023)  6 - p. e0000138 , 2023
Link: https://doi.org/10.1371/..
 
?
6

Adherence trajectory as an on-treatment risk indicator amon..:

Huddart, Sophie ; Geocaniga-Gaviola, Donna Mae ; Crowder, Rebecca...
PLOS ONE.  17 (2022)  11 - p. e0277078 , 2022
Link: https://doi.org/10.1371/..
 
?
7

The N-terminal disease–associated R5L Tau mutation increase..:

Cario, Alisa ; Wickramasinghe, Sanjula P. ; Rhoades, Elizabeth.
Journal of Biological Chemistry.  298 (2022)  11 - p. 102526 , 2022
Link: https://doi.org/10.1016/..
 
?
8

The pathogenic R5L mutation disrupts formation of Tau compl..:

Cario, Alisa ; Savastano, Adriana ; Wood, Neil B....
Proceedings of the National Academy of Sciences.  119 (2022)  7 - p. , 2022
Link: https://doi.org/10.1073/..
 
?
9

Completion of isoniazid–rifapentine (3HP) for tuberculosis ..:

Semitala, Fred C. ; Kadota, Jillian L. ; Musinguzi, Allan...
PLOS Medicine.  18 (2021)  12 - p. e1003875 , 2021
Link: https://doi.org/10.1371/..
 
?
10

Digital adherence technology for tuberculosis treatment sup..:

Cattamanchi, Adithya ; Crowder, Rebecca ; Kityamuwesi, Alex...
PLOS Medicine.  18 (2021)  5 - p. e1003628 , 2021
Link: https://doi.org/10.1371/..
 
?
11

Acceptance and completion of rifapentine-based TB preventiv..:

Semitala, Fred C. ; Musinguzi, Allan ; Ssemata, Jackie...
Implementation Science Communications.  2 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
12

Presentation and outcome of suspected sepsis in a high-HIV ..:

Chaka, Wendy ; Berger, Christopher ; Huo, Stella...
International Journal of Infectious Diseases.  96 (2020)  - p. 276-283 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Protocol for the 3HP Options Trial: a hybrid type 3 impleme..:

Kadota, Jillian L. ; Musinguzi, Allan ; Nabunje, Juliet...
Implementation Science.  15 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
14

Variation in tuberculosis treatment outcomes and treatment ..:

Berger, Christopher A. ; Kityamuwesi, Alex ; Crowder, Rebecca...
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.  21 (2020)  - p. 100184 , 2020
Link: https://doi.org/10.1016/..
 
?
15

Implementation science to improve the quality of tuberculos..:

Cattamanchi, Adithya ; Berger, Christopher A. ; Shete, Priya B....
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.  18 (2020)  - p. 100136 , 2020
Link: https://doi.org/10.1016/..
 
1-15